Comparative Intra-procedural Evaluation of Farapulse and FARAWAVE Nav Catheters
Recruiting
N/A
Interventional Study
Atrial Fibrillation (AF)
Atrial Fibrillation Ablation
Pulsed Field Ablation
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 58 (estimated)
- Sponsor
- Cardiocentro Ticino · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The FARAPULSE PFA catheter (Boston Scientific), a first-generation Pulsed Field Ablation (PFA) tool, has demonstrated good performance in isolating pulmonary veins (PV). Several centers, including ours, utilize pre-procedural computer tomography (CT) to evaluate individual pulmonary vein anatomy and optimize ablation planning. However, these imaging modalities are costly. Additionally, CT imaging …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Atrial fibrillation (AF) documented on a 12-lead ECG, Holter monitor, or implantable cardiac device.
* Candidate for ablation according to current atrial fibrillation guidelines.
* Age ≥18 years at the time of informed consent.
* Signed informed consent obtained
Exclusion Cri…
Contacts